Source: Boston Real Estate Times

Rpmasiello: RP Masiello breaks ground on new manufacturing facility for EyePoint Pharmaceuticals

Boylston, MA- RP Masiello is now building a new manufacturing facility for EyePoint Pharmaceuticals, a company that develops new treatments and drug-delivery systems for many challenging eye diseases, including macular [...] The post RP Masiello breaks ground on new manufacturing facility for EyePoint Pharmaceuticals appeared first on Boston Real Estate Times.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100